Jinling Liu

Assistant Professor and Principal Investigator

University of Florida
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

A novel framework for estimating personalized genomic variants of hypertension for precision medicine

Open Date: 2023-09-01

Close Date: 2027-07-31

Grant: Close

Investigation and deployment of novel Bayesian inference algorithms in CAVATICA for identifying genomic variants underlying congenital heart defects in Down syndrome individuals

Open Date: 2023-09-01

Close Date: 2025-04-30

Positions (1)

Publisher
source

Jinling Liu

University Name
.

University of Florida

The University of Florida’s Department of Epidemiology is seeking 1–2 postdoctoral associates for Dr. Jinling Liu’s laboratory and the Center for Genetic Epidemiology and Bioinformatics (GeneBio) in Gainesville. The research environment brings together epidemiology, public health, medicine, computational biology, and advanced data science. The lab works with large-scale human multi-omics datasets, including whole-genome sequencing, whole-exome sequencing, DNA methylation, RNA sequencing, proteomics, lipidomics, and metabolomics. Researchers integrate and mine these high-dimensional data types to investigate genomic causes, biomarkers, and underlying signaling networks associated with aging, cardiovascular disease, brain disease, cancer, and other conditions. Postdoctoral associates will contribute to multi-omics data analysis, development and application of statistical and deep-learning methods, manuscript preparation, conference presentations, grant development, and student mentoring. The position offers exposure to systems biology, probabilistic graphical models, causal inference, machine learning, precision medicine, and collaborations with experts across multiple fields. Dr. Liu’s laboratory is supported by the University of Florida’s College of Public Health and Health Professions, College of Medicine, Health Science Center, and associated research institutes and clinical partners, providing access to extensive biomedical datasets and a broad interdisciplinary research network.

3 days ago

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Cancer is mainly caused by a relatively small portion of somatic genome alterations (SGAs), called cancer drivers. Despite success in identifying a good number of cancer drivers, many more remain to be discovered to explain various cancers. Moreover, limited tools are available to identify potential interactions among cancer drivers for a better understanding of oncogenesis. To tackle these challenges, we have developed a novel approach called individualized Bayesian inference using a decision tree (IBI-DT). IBI-DT recognizes the genetic heterogeneity among cancer patients, where different individuals or patient subgroups of distinct genomic makeup may have different drivers. IBI-DT works by constructing smaller subgroups with similar genetic makeup (i.e. patient-like-me subgroups) using a decision tree structure and analyzing multiple trees to identify the SGAs that play a significant role in regulating downstream gene expression patterns at the subgroup and individual levels. This is distinct from population-based approaches, which tend to evaluate the influence of an SGA for the entire population, thereby likely missing low-frequency SGAs that may well explain a small subgroup of cancer patients. Also importantly, IBI-DT can efficiently identify cancer drivers that may have functional interactions. We applied IBI-DT to identify cancer drivers regulating the downstream differential gene expression in cancer patients and compared it to the standard, population-based method of expression quantitative trait loci analysis. Our results show that IBI-DT performs well in identifying both important cancer drivers, especially the low-frequency drivers, and their interactions, allowing for a better understanding of the cancer signaling pathways.

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Pei Geng

Assistant Professor

University of New Hampshire

UNITED STATES
View details

Xinghua Lu

Professor

University of Pittsburgh

UNITED STATES
View details

Yijia Gu

Assistant Professor

University of Florida

UNITED STATES
View details